Document Detail


Comparison of norepinephrine-dobutamine to epinephrine for hemodynamics, lactate metabolism, and organ function variables in cardiogenic shock. A prospective, randomized pilot study.
MedLine Citation:
PMID:  21037469     Owner:  NLM     Status:  In-Data-Review    
Abstract/OtherAbstract:
OBJECTIVE: : There is no study that has compared, in a randomized manner, which vasopressor is most suitable in optimizing both systemic and regional hemodynamics in cardiogenic shock patients. Hence, the present study was designed to compare epinephrine and norepinephrine-dobutamine in dopamine-resistant cardiogenic shock.
DESIGN: : Open, randomized interventional human study.
SETTING: : Medical intensive care unit in a university hospital.
PATIENTS: : Thirty patients with a cardiac index of <2.2 L/min/m and a mean arterial pressure of <60 mm Hg resistant to combined dopamine-dobutamine treatment and signs of shock. Patients were not included in cases of cardiogenic shock secondary to acute ischemic events such as myocardial infarction. Noninclusion criteria also included immediate indication of mechanical assistance.
INTERVENTIONS: : Patients were randomized to receive an infusion of either norepinephrine-dobutamine or epinephrine titrated to obtain a mean arterial pressure of between 65 and 70 mm Hg with a stable or increased cardiac index.
MAIN RESULTS: : Both regimens increased cardiac index and oxygen-derived parameters in a similar manner. Patients in the norepinephrine-dobutamine group demonstrated heart rates lower (p < .05) than those in the epinephrine group. Epinephrine infusion was associated with new arrhythmias in three patients. When compared to baseline values, after 6 hrs, epinephrine infusion was associated with an increase in lactate level (p < .01), whereas this level decreased in the norepinephrine-dobutamine group. Tonometered PCO2 gap, a surrogate for splanchnic perfusion adequacy, increased in the epinephrine-treated group (p < .01) while decreasing in the norepinephrine group (p < .01). Diuresis increased in both groups but significantly more so in the norepinephrine-dobutamine group, whereas plasma creatinine decreased in both groups.
CONCLUSIONS: : When considering global hemodynamic effects, epinephrine is as effective as norepinephrine-dobutamine. Nevertheless, epinephrine is associated with a transient lactic acidosis, higher heart rate and arrhythmia, and inadequate gastric mucosa perfusion. Thus, the combination norepinephrine-dobutamine appears to be a more reliable and safer strategy.
Authors:
Bruno Levy; Pierre Perez; Jessica Perny; Carine Thivilier; Alain Gerard
Related Documents :
8185419 - Clinical utility of digital dobutamine stress echocardiography in the noninvasive evalu...
7064859 - Future applications for the evaluation of ventricular function using echocardiography.
10532519 - Tailored therapy using dobutamine and nitroglycerin in advanced heart failure.
8347359 - Recovery of myocardial function. the ultimate target of coronary revascularization.
8680139 - Adenosine triphosphate stress echocardiography in the detection of myocardial ischemia.
10899059 - Maturation of end-systolic stress-strain relations in chick embryonic myocardium.
15561339 - Prevalence of right ventricular dysplasia-cardiomyopathy in a non-referral hospital.
22732179 - Everolimus: a challenging drug in the treatment of multifocal inoperable cardiac rhabdo...
7831149 - Cardiomyopathy in childhood and adult life, with emphasis on hypertrophic cardiomyopathy.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Critical care medicine     Volume:  39     ISSN:  1530-0293     ISO Abbreviation:  Crit. Care Med.     Publication Date:  2011 Mar 
Date Detail:
Created Date:  2011-02-18     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0355501     Medline TA:  Crit Care Med     Country:  United States    
Other Details:
Languages:  eng     Pagination:  450-5     Citation Subset:  AIM; IM    
Affiliation:
From Service de Réanimation Médicale (BL, PP, JP, CT, AG), CHU Nancy-Brabois, Vandoeuvre les Nancy, France; and Groupe Choc (BL), contrat AVENIR INSERM, Faculté de Médecine, Nancy Université, Nancy, France.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  mTOR inhibition in advanced renal cell carcinoma: which criteria should be used to evaluate therapeu...
Next Document:  Jejunal tube placement in critically ill patients: A prospective, randomized trial comparing the end...